Tim Kanters | Researcher
institute for Medical Technology Assessment, Erasmus University Rotterdam

Tim Kanters, Researcher, institute for Medical Technology Assessment, Erasmus University Rotterdam

Tim Kanters (PhD) is a senior scientific researcher at the institute for Medical Technology Assessment (iMTA), part of the Erasmus University Rotterdam. In this role, he is involved in cost-effectiveness studies, costing studies and real-world evidence studies in various clinical areas. He was involved in the two latest revisions of the Dutch costing manual for economic evaluations. His dissertation focussed on the cost-effectiveness of orphan drugs.

Appearances:



Day 2 @ 11:15

Panel: From Patient Voice to HTA Evidence: Insights from the EU-Funded PaLaDIn project

last published: 22/Oct/26 12:27 GMT

back to speakers

Get involved at World Orphan Drug Congress Europe 2026

 

 

TO SPONSOR


Steph Scanlon

Steph.Scanlon@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com